United States · FDA National Drug Code directory
Pazopanib
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 59651-582_25575cc6-5757-4f9b-9c09-0c4deb61ba12
- Product NDC
- 59651-582
- Form
- TABLET, FILM COATED
- Composition / generic term
- Pazopanib
- Labeler
- Aurobindo Pharma Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20241204
- Source listing expiry
- 20261231
Source-listed ingredients
- PAZOPANIB HYDROCHLORIDE — 200 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 120 TABLET, FILM COATED in 1 BOTTLE (59651-582-08) · 59651-582-08
- 30 TABLET, FILM COATED in 1 BOTTLE (59651-582-30) · 59651-582-30
- 90 TABLET, FILM COATED in 1 BOTTLE (59651-582-90) · 59651-582-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →